Valsartan, a blood pressure medication, was recently recalled by several companies because the drug was contaminated with NDMA, a cancer-causing substance (which has also been previously used in rocket fuel production). Studies have shown that the pills contain up to 177 times the level of NDMA considered safe for consumption.
In 2018, the FDA reported that Valsartan produced by Chinese manufacturers Zhejiang Huahai Pharmaceuticals and Zhejiang Tianyu Pharmaceuticals contained this cancer-causing substance, yet have sold the contaminated Valsartan to several major drug makers. In addition, the FDA recalled some Valsartan products manufactured by Hetero Labs Limited, in India, labeled as Camber Pharmaceuticals Inc. This company is among 40 other companies sued over manufacturing such generic drug, which includes Teva Pharmaceutical Industries Ltd., Mylan NV, and CVS Health Corp. Two months ago at a New Jersey hearing, attorneys held that in 2018, potentially over a million people nationwide consumed the contaminated Valsartan.
If you or your loved one have been diagnosed with gastrointestinal, kidney, stomach, liver, lung, bladder, pancreatic, or colon cancer after taking Valsartan, contact Alan Ripka & Associates. Alan Ripka Esq. and his team of lawyers are currently investigating cases involving recalled Valsartan medication. Ripka has fought against large companies in other matters and will fight for you if he believes you have a potential case for medical malpractice, products liability, personal injury, and is prepared to go to court and have a trial if necessary. Call Alan Ripka & Associates at 212-557-4777. Our experienced team is here to evaluate your situation and determine the next steps to gain justice for you and your family.